Camacho-Barcia, L. http://orcid.org/0000-0002-5989-936X
Munguía, L. http://orcid.org/0000-0002-9751-810X
Gaspar-Pérez, A. http://orcid.org/0000-0002-1427-3697
Jimenez-Murcia, S. http://orcid.org/0000-0002-3596-8033
Fernández-Aranda, F. http://orcid.org/0000-0002-2968-9898
Funding for this research was provided by:
Ministerio de Economia y Competitividad (PSI2015‐68701‐R)
Delegacion del Gobierno para el plan Nacional sobre Drogas (2017I067, 2019I)
Instituto de Salud Carlos III (FIS PI20/132, PI17/01167)
Article History
Accepted: 16 June 2022
First Online: 27 June 2022
Declarations
:
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
: FFA received consultancy honoraria from Novo Nordisk and editorial honoraria as EIC from Wiley. The rest of the authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.